Erectile Dysfunction Drugs Market Size, Share & Trends Report

Erectile Dysfunction Drugs Market Size, Share & Trends Analysis Report By Product (Viagra, Cialis, Zydena, Levitra, Stendra, Others), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-604-2
  • Number of Pages: 79
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Product
                        1.1.2. Regional scope
                        1.1.3. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Erectile Dysfunction Drugs Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market driver analysis
                        3.3.2. Market restraint analysis
                    3.4. Erectile Dysfunction Drugs Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s Five Forces
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic landscape
Chapter 4. Erectile Dysfunction Drugs Market: Product Estimates & Trend Analysis
                    4.1. Erectile Dysfunction Drugs Market: Key Takeaways
                    4.2. Erectile Dysfunction Drugs Market: Product Movement & Market Share Analysis, 2022 & 2030
                    4.3. Viagra
                        4.3.1. Viagra market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.4. Cialis
                        4.4.1. Cialis market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.5. Zydena
                        4.5.1. Zydena market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.6. Levitra
                        4.6.1. Levitra market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.7. Stendra
                        4.7.1. Stendra market estimates and forecasts, 2018 to 2030 (USD Million)
                    4.8. Others
                        4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Erectile Dysfunction Drugs Market: Regional Estimates & Trend Analysis
                    5.1. Regional Outlook
                    5.2. Erectile Dysfunction Drugs Market by Region: Key Takeaways
                    5.3. North America
                        5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.3.2. U.S.
                            5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.3.3. Canada
                            5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.4. Europe
                        5.4.1. UK
                            5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.2. Germany
                            5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.3. France
                            5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.4. Italy
                            5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.5. Spain
                            5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.6. Sweden
                            5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.7. Norway
                            5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.4.8. Denmark
                            5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.5. Asia Pacific
                        5.5.1. Japan
                            5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.2. China
                            5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.3. India
                            5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.4. Australia
                            5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.5. Thailand
                            5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.5.6. South Korea
                            5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.6. Latin America
                        5.6.1. Brazil
                            5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.6.2. Mexico
                            5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.6.3. Argentina
                            5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                    5.7. MEA
                        5.7.1. Saudi Arabia
                            5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.7.2. South Africa
                            5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.7.3. UAE
                            5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                        5.7.4. Kuwait
                            5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Market Participant Categorization
                        6.2.1. Pfizer, Inc.
                            6.2.1.1. Company overview
                            6.2.1.2. Financial performance
                            6.2.1.3. Product benchmarking
                            6.2.1.4. Strategic initiatives
                        6.2.2. Eli Lilly and Company
                            6.2.2.1. Company overview
                            6.2.2.2. Financial performance
                            6.2.2.3. Product benchmarking
                            6.2.2.4. Strategic initiatives
                        6.2.3. Teva Pharmaceutical Industries Ltd.
                            6.2.3.1. Company overview
                            6.2.3.2. Financial performance
                            6.2.3.3. Product benchmarking
                            6.2.3.4. Strategic initiatives
                        6.2.4. Sanofi
                            6.2.4.1. Company overview
                            6.2.4.2. Financial performance
                            6.2.4.3. Product benchmarking
                            6.2.4.4. Strategic initiatives
                        6.2.5. Sun Pharmaceutical Industries Ltd.
                            6.2.5.1. Company overview
                            6.2.5.2. Financial performance
                            6.2.5.3. Product benchmarking
                            6.2.5.4. Strategic initiatives
                        6.2.6. Bayer AG
                            6.2.6.1. Company overview
                            6.2.6.2. Financial performance
                            6.2.6.3. Product benchmarking
                            6.2.6.4. Strategic initiatives
                        6.2.7. Petros Pharmaceuticals, Inc.
                            6.2.7.1. Company overview
                            6.2.7.2. Financial performance
                            6.2.7.3. Product benchmarking
                            6.2.7.4. Strategic initiatives
                        6.2.8. VIVUS, Inc.
                            6.2.8.1. Company overview
                            6.2.8.2. Financial performance
                            6.2.8.3. Product benchmarking
                            6.2.8.4. Strategic initiatives
                        6.2.9. Auxilium Pharmaceuticals
                            6.2.9.1. Company overview
                            6.2.9.2. Financial performance
                            6.2.9.3. Product benchmarking
                            6.2.9.4. Strategic initiatives
                        6.2.10. Adamed
                            6.2.10.1. Company overview
                            6.2.10.2. Financial performance
                            6.2.10.3. Product benchmarking
                            6.2.10.4. Strategic initiatives
                        6.2.11. Cipla Inc.
                            6.2.11.1. Company overview
                            6.2.11.2. Financial performance
                            6.2.11.3. Product benchmarking
                            6.2.11.4. Strategic initiatives


List of Tables

Table 1 List of abbreviations
Table 2 North America erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 3 North America erectile dysfunction drugs market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 5 Canada erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 6 Europe erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 7 Europe erectile dysfunction drugs market, by region, 2018 - 2030 (USD Million)
Table 8 Germany erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 9 UK erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 10 France erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 11 Italy erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 12 Spain erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 13 Sweden erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 14 Norway erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 15 Denmark erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 16 Asia Pacific erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 17 Asia Pacific erectile dysfunction drugs market, by region, 2018 - 2030 (USD Million)
Table 18 Japan erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 19 China erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 20 India erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 21 Australia erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 22 Thailand erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 23 South Korea erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 24 Latin America erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 25 Latin America erectile dysfunction drugs market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 27 Mexico erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 28 Argentina erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa erectile dysfunction drugs market, by region, 2018 - 2030 (USD Million)
Table 31 South Africa erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 33 UAE erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)
Table 34 Kuwait erectile dysfunction drugs market, by product, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Erectile dysfunction drugs: Market outlook
Fig. 9 Erectile dysfunction drugs: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Erectile dysfunction drugs market driver impact
Fig. 15 Erectile dysfunction drugs market restraint impact
Fig. 16 Erectile dysfunction drugs market strategic initiatives analysis
Fig. 17 Erectile dysfunction drugs market: Product movement analysis
Fig. 18 Erectile dysfunction drugs market: Product outlook and key takeaways
Fig. 19 Viagra market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 20 Cialis market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 21 Zydena market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 22 Levitra market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 23 Stendra market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 25 Global erectile dysfunction drugs market: Regional movement analysis
Fig. 26 Global erectile dysfunction drugs market: Regional outlook and key takeaways
Fig. 27 North America market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 28 U.S. market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 29 Canada market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 30 Europe market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 31 UK market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 32 Germany market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 33 France market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 34 Italy market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 35 Spain market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 36 Sweden market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 37 Norway market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 38 Denmark market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 39 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 40 Japan market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 41 China market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 42 India market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 43 Australia market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 44 Thailand market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 45 South Korea market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 46 Latin America market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 47 Brazil market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 48 Mexico market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 49 Argentina market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 50 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 51 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 52 South Africa market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 53 UAE market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 54 Kuwait market estimates and forecasts, 2018 - 2030 (USD million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon